Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-159,482
Closed -$1M 1513
2021
Q4
$1M Sell
159,482
-7,183
-4% -$49K 0.03% 534
2021
Q3
$1.32M Sell
166,665
-55,215
-25% -$454K 0.04% 439
2021
Q2
$1.66M Sell
221,880
-36,145
-14% -$252K 0.05% 382
2021
Q1
$1.56M Buy
258,025
+4,875
+2% +$37.5K 0.06% 372
2020
Q4
$1.45M Buy
253,150
+70,654
+39% +$449K 0.08% 253
2020
Q3
$1.21M Buy
182,496
+134,461
+280% +$1.2M 0.06% 281
2020
Q2
$426K Buy
+48,035
New +$138K 0.03% 510

Other funds holding VXRT

B. Riley Wealth Advisors's VXRT Position: Q1 2022 in Review

B. Riley Wealth Advisors sold out of Vaxart (VXRT) in Q1 2022, closing a stake of 159,482 shares — an estimated $1M sold.

B. Riley Wealth Advisors first reported a position in VXRT in Q2 2020 and held it in 7 quarters. The position peaked at $1.66M in Q2 2021. 148 funds tracked by Wall St. Rank hold VXRT as of Q1 2022.

  • B. Riley Wealth Advisors reported no remaining Vaxart position as of Q1 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 159,482 Vaxart shares in Q1 2022, an estimated $1M.
  • B. Riley Wealth Advisors first reported a position in Vaxart in Q2 2020 and held it in 7 quarters.
  • B. Riley Wealth Advisors's Vaxart position peaked at $1.66M in Q2 2021.
  • 148 funds tracked by Wall St. Rank held Vaxart as of Q1 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2022, filed 2 May 2022.